David Alan Barta - 27 Jan 2022 Form 4 Insider Report for Exterran Corp

Reporting relationship: SVP, CFO, and CAO
Issuer ticker: N/A
Reported as of: 27 Jan 2022
Net transaction value: +$952
SEC form: 4
Accepted by SEC: 28 Jan 2022, 14:38:10 UTC
Prior SEC filing: 12 May 2021
Next SEC filing: 08 Mar 2022
Source filing: View source filing
Reporting owner signature: /s/ Kelly M. Battle Attorney-in-Fact

Key filing fact

David Alan Barta filed Form 4 for Exterran Corp on 28 Jan 2022.

Key facts

This page summarizes David Alan Barta's Form 4 filing for Exterran Corp.
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 28 Jan 2022, 14:38.

Change

Previous filing in this sequence was filed on 12 May 2021.
Current net transaction value: +$952.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EXTN transaction

Common Stock

Sale

Transaction value: $33,728
Shares: -6,800
Change %: -7.6%
Price: $4.96
Shares after: 82,967
Date: 27 Jan 2022
Ownership: Direct
Footnotes: F1, F2

EXTN transaction

Common Stock

Purchase

Transaction value: $34,680
Shares: +6,800
Change %: +8.2%
Price: $5.10
Shares after: 89,767
Date: 28 Jan 2022
Ownership: Direct
Footnotes: F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The reporting person did not direct the sale of shares. The sale is a result of a liquidation of the reporting person's Health Savings Account as required to transfer to a new company provider. This liquidation is consistent with all participants in the Health Savings Account and not specific to the reporting person.

Footnote F2

The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $4.95 to $4.98, inclusive.

Footnote F3

Due to the disposition of shares from the reporting persons Health Savings Account, the reporting person purchased replacement shares in the identical amount as those disposed.

Footnote F4

The price reported is a weighted average price. The shares were repurchased in multiple transactions ranging from $5.09 to $5.11, inclusive.